Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-24-046462
Filing Date
2024-11-07
Accepted
2024-11-07 19:20:55
Documents
1
Period of Report
2024-11-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1731025248.html 4  
1 FORM 4 wk-form4_1731025248.xml 4 3290
  Complete submission text file 0001628280-24-046462.txt   4806
Mailing Address 1800 OWENS STREET SUITE 900 SAN FRANCISCO CA 94158
Business Address 1800 OWENS STREET SUITE 900 SAN FRANCISCO CA 94158 415-906-4324
Vir Biotechnology, Inc. (Issuer) CIK: 0001706431 (see all company filings)

EIN.: 812730369 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O VIR BIOTECHNOLOGY, INC. 1800 OWENS STREET, SUITE 900 SAN FRANCISCO CA 94158
Business Address
de Verneuil Vanina (Reporting) CIK: 0002036234 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39083 | Film No.: 241437589